BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16556817)

  • 1. Genetics. A clearer view of macular degeneration.
    Marx J
    Science; 2006 Mar; 311(5768):1704-5. PubMed ID: 16556817
    [No Abstract]   [Full Text] [Related]  

  • 2. Protective effect of complement factor B and complement component 2 variants in age-related macular degeneration.
    Spencer KL; Hauser MA; Olson LM; Schmidt S; Scott WK; Gallins P; Agarwal A; Postel EA; Pericak-Vance MA; Haines JL
    Hum Mol Genet; 2007 Aug; 16(16):1986-92. PubMed ID: 17576744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-related macular degeneration: a perspective on genetic studies.
    Patel N; Adewoyin T; Chong NV
    Eye (Lond); 2008 Jun; 22(6):768-76. PubMed ID: 17491602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Genetics and ARMD: from the laboratory to the consulting room].
    García Layana A; Zarranz-Ventura J; Fernández Robredo P; Recalde S; Rodríguez de Córdoba S;
    Arch Soc Esp Oftalmol; 2011 Apr; 86(4):101-2. PubMed ID: 21569917
    [No Abstract]   [Full Text] [Related]  

  • 5. LOC387715/HTRA1 and complement factor H variants in patients with age-related macular degeneration seen at the mayo clinic.
    Pulido JS; Peterson LM; Mutapcic L; Bryant S; Highsmith WE
    Ophthalmic Genet; 2007 Dec; 28(4):203-7. PubMed ID: 18161619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms in C2, CFB and C3 are associated with progression to advanced age related macular degeneration associated with visual loss.
    Francis PJ; Hamon SC; Ott J; Weleber RG; Klein ML
    J Med Genet; 2009 May; 46(5):300-7. PubMed ID: 19015224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacogenetics and age-related macular degeneration, towards an individualized treatment of the disease].
    Cruz-González F; Cabrillo Estévez L; López-Valverde G; Escudero-Domínguez F; González-Sarmiento R
    Arch Soc Esp Oftalmol; 2013 Oct; 88(10):371-2. PubMed ID: 24060299
    [No Abstract]   [Full Text] [Related]  

  • 8. Complement regulation at necrotic cell lesions is impaired by the age-related macular degeneration-associated factor-H His402 risk variant.
    Lauer N; Mihlan M; Hartmann A; Schlötzer-Schrehardt U; Keilhauer C; Scholl HP; Charbel Issa P; Holz F; Weber BH; Skerka C; Zipfel PF
    J Immunol; 2011 Oct; 187(8):4374-83. PubMed ID: 21930971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of genetic factors and inflammation in age-related macular degeneration.
    Moshfeghi DM; Blumenkranz MS
    Retina; 2007 Mar; 27(3):269-75. PubMed ID: 17460581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of the C-460T polymorphism of the vascular endothelial growth factor gene in age-related macular degeneration.
    Szaflik JP; Błasiak J; Krzyanowska A; Zaraś M; Janik-Papis K; Borucka AI; Woźniak K; Szaflik J
    Klin Oczna; 2009; 111(4-6):125-7. PubMed ID: 19673440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-related macular degeneration genetics.
    Recalde S; Fernandez-Robredo P; Altarriba M; Salinas-Alaman A; García-Layana A
    Ophthalmology; 2008 May; 115(5):916-916.e1. PubMed ID: 18452766
    [No Abstract]   [Full Text] [Related]  

  • 12. Complement factor H and macular degeneration: the genome yields an important clue.
    Wiggs JL
    Arch Ophthalmol; 2006 Apr; 124(4):577-8. PubMed ID: 16606888
    [No Abstract]   [Full Text] [Related]  

  • 13. Further mapping of 10q26 supports strong association of HTRA1 polymorphisms with age-related macular degeneration.
    Gibbs D; Yang Z; Constantine R; Ma X; Camp NJ; Yang X; Chen H; Jorgenson A; Hau V; Dewan A; Zeng J; Harmon J; Buehler J; Brand JM; Hoh J; Cameron DJ; Dixit M; Tong Z; Zhang K
    Vision Res; 2008 Feb; 48(5):685-9. PubMed ID: 18207215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of complement factor H Y402H polymorphism with phenotype of neovascular age related macular degeneration in Israel.
    Chowers I; Cohen Y; Goldenberg-Cohen N; Vicuna-Kojchen J; Lichtinger A; Weinstein O; Pollack A; Axer-Siegel R; Hemo I; Averbukh E; Banin E; Meir T; Lederman M
    Mol Vis; 2008; 14():1829-34. PubMed ID: 18852870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An update on the genetics of age-related macular degeneration.
    Scholl HP; Fleckenstein M; Charbel Issa P; Keilhauer C; Holz FG; Weber BH
    Mol Vis; 2007 Feb; 13():196-205. PubMed ID: 17327825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-related macular degeneration: Complement in action.
    van Lookeren Campagne M; Strauss EC; Yaspan BL
    Immunobiology; 2016 Jun; 221(6):733-9. PubMed ID: 26742632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress in defining the molecular biology of age related macular degeneration.
    Lotery A; Trump D
    Hum Genet; 2007 Nov; 122(3-4):219-36. PubMed ID: 17659362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the Y402H variant of the complement factor H gene in age-related macular degeneration.
    Baird PN; Islam FM; Richardson AJ; Cain M; Hunt N; Guymer R
    Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4194-8. PubMed ID: 17003406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-related macular degeneration genetics.
    Byeon SH; Chu YK
    Ophthalmology; 2011 Mar; 118(3):600-1. PubMed ID: 21376244
    [No Abstract]   [Full Text] [Related]  

  • 20. A Novel Complotype Combination Associates with Age-Related Macular Degeneration and High Complement Activation Levels in vivo.
    Paun CC; Lechanteur YTE; Groenewoud JMM; Altay L; Schick T; Daha MR; Fauser S; Hoyng CB; den Hollander AI; de Jong EK
    Sci Rep; 2016 May; 6():26568. PubMed ID: 27241480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.